Biotech-focused SPAC Sparta Healthcare Acquisition files for a $100 million IPO
Sparta Healthcare Acquisition is led by CEO and Chairman Michael Handley, who has served as the CEO of Cytocom since 2020 and has assisted in or led the global commercialization of 17 devices or drugs over the course of his career, and CFO Nicholas Hemmerly, the current Head of Investment Banking at Bridgeway Capital Partners. The company plans to leverage management's experience and target the North American biotech and therapeutic sectors, focusing on businesses with mid-to-late stage therapeutic candidates across a variety of indications.
Market Data 
Markets 
AI
